HEADER OXIDOREDUCTASE 28-JAN-21 7E0O TITLE CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENAGSE 1 (HIDO1) TITLE 2 COMPLEXED WITH 6-BROMO-1H-INDAZOL-4-AMINE (1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDOLEAMINE 2,3-DIOXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IDO-1,INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE; COMPND 5 EC: 1.13.11.52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IDO1, IDO, INDO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INDOLEAMINE 2, 3-DIOXYGENASE 1, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR G.-B.LI,X.-L.NING REVDAT 3 23-OCT-24 7E0O 1 REMARK REVDAT 2 29-NOV-23 7E0O 1 REMARK REVDAT 1 21-JUL-21 7E0O 0 JRNL AUTH X.L.NING,Y.Z.LI,C.HUO,J.DENG,C.GAO,K.R.ZHU,M.WANG,Y.X.WU, JRNL AUTH 2 J.L.YU,Y.L.REN,Z.Y.LUO,G.LI,Y.CHEN,S.Y.WANG,C.PENG,L.L.YANG, JRNL AUTH 3 Z.Y.WANG,Y.WU,S.QIAN,G.B.LI JRNL TITL X-RAY STRUCTURE-GUIDED DISCOVERY OF A POTENT, ORALLY JRNL TITL 2 BIOAVAILABLE, DUAL HUMAN INDOLEAMINE/TRYPTOPHAN JRNL TITL 3 2,3-DIOXYGENASE (HIDO/HTDO) INHIBITOR THAT SHOWS ACTIVITY IN JRNL TITL 4 A MOUSE MODEL OF PARKINSON'S DISEASE. JRNL REF J.MED.CHEM. V. 64 8303 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34110158 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00303 REMARK 2 REMARK 2 RESOLUTION. 3.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 15786 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.302 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1578 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 65.4920 - 7.4173 0.99 1435 159 0.1796 0.2401 REMARK 3 2 7.4173 - 5.8885 1.00 1377 154 0.2056 0.2869 REMARK 3 3 5.8885 - 5.1445 1.00 1345 150 0.2009 0.2924 REMARK 3 4 5.1445 - 4.6743 0.99 1335 148 0.1757 0.2734 REMARK 3 5 4.6743 - 4.3393 1.00 1329 148 0.1938 0.2798 REMARK 3 6 4.3393 - 4.0835 0.99 1306 144 0.2002 0.3350 REMARK 3 7 4.0835 - 3.8791 0.99 1315 147 0.2178 0.3346 REMARK 3 8 3.8791 - 3.7102 1.00 1309 144 0.2530 0.3546 REMARK 3 9 3.7102 - 3.5674 0.99 1324 146 0.3249 0.5195 REMARK 3 10 3.5674 - 3.4443 0.89 1084 120 0.3080 0.4071 REMARK 3 11 3.4443 - 3.3370 0.96 1049 118 0.3357 0.3915 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.510 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 104.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.019 6139 REMARK 3 ANGLE : 1.703 8332 REMARK 3 CHIRALITY : 0.059 900 REMARK 3 PLANARITY : 0.010 1056 REMARK 3 DIHEDRAL : 18.412 3633 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7E0O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300020539. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 195 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X CDTE 1M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROCESS REMARK 200 DATA SCALING SOFTWARE : WEB-ICE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15866 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.337 REMARK 200 RESOLUTION RANGE LOW (A) : 71.652 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 13.37 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.39 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5ETW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% TO 23% PEG 8000, 0.2M AMMONIUM REMARK 280 ACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.79700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.49150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.39650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.49150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.79700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.39650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 361 REMARK 465 PRO A 362 REMARK 465 LYS A 363 REMARK 465 GLU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 THR A 367 REMARK 465 SER A 368 REMARK 465 GLU A 369 REMARK 465 ASP A 370 REMARK 465 PRO A 371 REMARK 465 SER A 372 REMARK 465 LYS A 373 REMARK 465 LEU A 374 REMARK 465 GLU A 375 REMARK 465 ALA A 376 REMARK 465 LYS A 377 REMARK 465 GLY A 378 REMARK 465 THR A 379 REMARK 465 LYS A 401 REMARK 465 GLU A 402 REMARK 465 GLY A 403 REMARK 465 GLN B 361 REMARK 465 PRO B 362 REMARK 465 LYS B 363 REMARK 465 GLU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 THR B 367 REMARK 465 SER B 368 REMARK 465 GLU B 369 REMARK 465 ASP B 370 REMARK 465 PRO B 371 REMARK 465 SER B 372 REMARK 465 LYS B 373 REMARK 465 LEU B 374 REMARK 465 GLU B 375 REMARK 465 ALA B 376 REMARK 465 LYS B 377 REMARK 465 GLY B 378 REMARK 465 THR B 379 REMARK 465 LYS B 401 REMARK 465 GLU B 402 REMARK 465 GLY B 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 13 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 171 OG SER B 267 2.05 REMARK 500 OD1 ASP B 72 OG SER B 75 2.07 REMARK 500 NH2 ARG B 317 O SER B 398 2.07 REMARK 500 OE1 GLN B 29 OG SER B 75 2.09 REMARK 500 NH2 ARG A 80 OD2 ASP A 128 2.09 REMARK 500 O LEU B 342 N TYR B 345 2.13 REMARK 500 OD2 ASP B 274 NH2 ARG B 343 2.14 REMARK 500 N MET A 64 OD1 ASN A 106 2.17 REMARK 500 O SER B 268 N PHE B 270 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 100 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 CYS A 129 CA - CB - SG ANGL. DEV. = 7.0 DEGREES REMARK 500 CYS B 85 CA - CB - SG ANGL. DEV. = 9.0 DEGREES REMARK 500 LEU B 201 CB - CG - CD1 ANGL. DEV. = -10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 13 -119.28 -54.12 REMARK 500 ASN A 27 73.34 57.69 REMARK 500 TYR A 36 46.33 -140.89 REMARK 500 TRP A 39 -73.35 -69.21 REMARK 500 ILE A 42 -75.20 -52.25 REMARK 500 ALA A 43 -37.45 -32.54 REMARK 500 SER A 52 10.14 -68.42 REMARK 500 ARG A 56 24.28 -78.43 REMARK 500 GLU A 60 -58.45 -15.28 REMARK 500 ASP A 68 -37.76 -24.91 REMARK 500 THR A 71 -76.51 -102.51 REMARK 500 HIS A 73 -70.19 -57.18 REMARK 500 PRO A 104 151.85 -48.00 REMARK 500 SER A 115 -72.31 -67.04 REMARK 500 LYS A 116 -8.91 -52.81 REMARK 500 GLU A 119 64.89 38.23 REMARK 500 PRO A 122 73.11 -69.00 REMARK 500 VAL A 130 -38.44 -134.18 REMARK 500 ASN A 133 64.21 -60.28 REMARK 500 PRO A 139 36.06 -79.00 REMARK 500 ASN A 140 -4.37 -140.98 REMARK 500 LEU A 143 88.75 -66.59 REMARK 500 CYS A 159 -7.36 82.03 REMARK 500 SER A 160 -23.48 -25.54 REMARK 500 GLU A 171 -27.61 -31.64 REMARK 500 GLN A 191 101.91 54.10 REMARK 500 GLU A 192 75.40 -157.25 REMARK 500 ALA A 210 -6.17 -50.19 REMARK 500 PHE A 214 -22.27 -28.99 REMARK 500 ILE A 217 -38.86 -39.80 REMARK 500 VAL A 229 -90.08 -80.23 REMARK 500 LEU A 230 -74.39 -37.24 REMARK 500 ARG A 231 -43.48 -23.23 REMARK 500 PHE A 252 -50.31 -148.63 REMARK 500 VAL A 269 -107.58 -68.19 REMARK 500 PHE A 270 -65.61 -1.89 REMARK 500 LEU A 277 23.14 -67.41 REMARK 500 PHE A 291 -90.79 -43.89 REMARK 500 LEU A 292 -20.70 -37.33 REMARK 500 PRO A 300 -165.05 -38.28 REMARK 500 LEU A 310 -71.19 -64.09 REMARK 500 SER A 315 107.03 -46.80 REMARK 500 ALA A 326 -13.49 -49.64 REMARK 500 ILE A 354 -34.01 -135.56 REMARK 500 THR A 382 -63.43 -22.73 REMARK 500 ASP A 383 -33.19 -35.74 REMARK 500 THR A 390 -30.53 -32.25 REMARK 500 LYS A 397 26.79 -63.23 REMARK 500 HIS B 16 71.26 74.67 REMARK 500 ASN B 27 52.93 32.92 REMARK 500 REMARK 500 THIS ENTRY HAS 89 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 502 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 346 NE2 REMARK 620 2 HEM A 502 NA 104.8 REMARK 620 3 HEM A 502 NB 93.2 92.7 REMARK 620 4 HEM A 502 NC 83.1 171.0 82.4 REMARK 620 5 HEM A 502 ND 92.0 92.5 171.5 91.6 REMARK 620 6 HS0 A 501 N08 161.1 92.3 77.9 79.3 95.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 502 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 346 NE2 REMARK 620 2 HEM B 502 NA 80.1 REMARK 620 3 HEM B 502 NB 103.2 84.2 REMARK 620 4 HEM B 502 NC 109.7 168.9 88.2 REMARK 620 5 HEM B 502 ND 84.7 93.7 171.4 92.5 REMARK 620 6 HS0 B 501 N08 168.4 91.0 83.2 79.9 88.5 REMARK 620 N 1 2 3 4 5 DBREF 7E0O A 12 403 UNP P14902 I23O1_HUMAN 12 403 DBREF 7E0O B 12 403 UNP P14902 I23O1_HUMAN 12 403 SEQRES 1 A 392 SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE ALA SEQRES 2 A 392 LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR ASN SEQRES 3 A 392 ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU ILE SEQRES 4 A 392 GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU ASN SEQRES 5 A 392 MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER GLN SEQRES 6 A 392 ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET ALA SEQRES 7 A 392 TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS VAL SEQRES 8 A 392 LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SER SEQRES 9 A 392 LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA ASP SEQRES 10 A 392 CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN LYS SEQRES 11 A 392 PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER PHE SEQRES 12 A 392 ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SER SEQRES 13 A 392 LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS VAL SEQRES 14 A 392 ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU ARG SEQRES 15 A 392 ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER CYS SEQRES 16 A 392 LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS ASP SEQRES 17 A 392 HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG ILE SEQRES 18 A 392 TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER ASP SEQRES 19 A 392 GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS GLU SEQRES 20 A 392 PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE GLN SEQRES 21 A 392 CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA GLY SEQRES 22 A 392 GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG ARG SEQRES 23 A 392 TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER LEU SEQRES 24 A 392 GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER LYS SEQRES 25 A 392 GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS VAL SEQRES 26 A 392 LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN ILE SEQRES 27 A 392 VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN PRO SEQRES 28 A 392 LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU GLU SEQRES 29 A 392 ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE LEU SEQRES 30 A 392 LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU LYS SEQRES 31 A 392 GLU GLY SEQRES 1 B 392 SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE ALA SEQRES 2 B 392 LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR ASN SEQRES 3 B 392 ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU ILE SEQRES 4 B 392 GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU ASN SEQRES 5 B 392 MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER GLN SEQRES 6 B 392 ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET ALA SEQRES 7 B 392 TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS VAL SEQRES 8 B 392 LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SER SEQRES 9 B 392 LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA ASP SEQRES 10 B 392 CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN LYS SEQRES 11 B 392 PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER PHE SEQRES 12 B 392 ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SER SEQRES 13 B 392 LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS VAL SEQRES 14 B 392 ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU ARG SEQRES 15 B 392 ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER CYS SEQRES 16 B 392 LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS ASP SEQRES 17 B 392 HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG ILE SEQRES 18 B 392 TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER ASP SEQRES 19 B 392 GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS GLU SEQRES 20 B 392 PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE GLN SEQRES 21 B 392 CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA GLY SEQRES 22 B 392 GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG ARG SEQRES 23 B 392 TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER LEU SEQRES 24 B 392 GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER LYS SEQRES 25 B 392 GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS VAL SEQRES 26 B 392 LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN ILE SEQRES 27 B 392 VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN PRO SEQRES 28 B 392 LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU GLU SEQRES 29 B 392 ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE LEU SEQRES 30 B 392 LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU LYS SEQRES 31 B 392 GLU GLY HET HS0 A 501 11 HET HEM A 502 43 HET HS0 B 501 11 HET HEM B 502 43 HETNAM HS0 6-BROMANYL-1~{H}-INDAZOL-4-AMINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 3 HS0 2(C7 H6 BR N3) FORMUL 4 HEM 2(C34 H32 FE N4 O4) HELIX 1 AA1 PRO A 33 PHE A 35 5 3 HELIX 2 AA2 TYR A 36 HIS A 45 1 10 HELIX 3 AA3 HIS A 45 SER A 52 1 8 HELIX 4 AA4 GLN A 54 VAL A 59 1 6 HELIX 5 AA5 SER A 66 LEU A 70 5 5 HELIX 6 AA6 ASP A 72 GLY A 93 1 22 HELIX 7 AA7 VAL A 109 LEU A 118 1 10 HELIX 8 AA8 VAL A 125 VAL A 130 1 6 HELIX 9 AA9 CYS A 159 SER A 176 1 18 HELIX 10 AB1 VAL A 180 GLN A 191 1 12 HELIX 11 AB2 GLU A 192 GLU A 208 1 17 HELIX 12 AB3 LYS A 209 HIS A 215 1 7 HELIX 13 AB4 GLN A 216 VAL A 221 1 6 HELIX 14 AB5 ASN A 222 VAL A 229 1 8 HELIX 15 AB6 VAL A 229 SER A 235 1 7 HELIX 16 AB7 SER A 263 GLN A 266 5 4 HELIX 17 AB8 SER A 267 LEU A 277 1 11 HELIX 18 AB9 GLY A 286 MET A 295 1 10 HELIX 19 AC1 HIS A 303 SER A 312 1 10 HELIX 20 AC2 ARG A 317 GLY A 324 1 8 HELIX 21 AC3 ASP A 325 ILE A 354 1 30 HELIX 22 AC4 ILE A 354 SER A 359 1 6 HELIX 23 AC5 GLY A 381 LYS A 397 1 17 HELIX 24 AC6 TYR B 36 HIS B 45 1 10 HELIX 25 AC7 HIS B 45 GLY B 53 1 9 HELIX 26 AC8 GLN B 54 LYS B 61 1 8 HELIX 27 AC9 SER B 66 LEU B 70 5 5 HELIX 28 AD1 ASP B 72 GLY B 93 1 22 HELIX 29 AD2 PRO B 104 GLU B 119 1 16 HELIX 30 AD3 VAL B 125 VAL B 130 1 6 HELIX 31 AD4 CYS B 159 ILE B 172 1 14 HELIX 32 AD5 VAL B 180 MET B 190 1 11 HELIX 33 AD6 GLU B 192 PHE B 214 1 23 HELIX 34 AD7 HIS B 215 HIS B 220 5 6 HELIX 35 AD8 ASN B 222 VAL B 229 1 8 HELIX 36 AD9 VAL B 229 SER B 235 1 7 HELIX 37 AE1 SER B 263 SER B 267 5 5 HELIX 38 AE2 VAL B 269 LEU B 277 1 9 HELIX 39 AE3 GLY B 286 MET B 295 1 10 HELIX 40 AE4 PRO B 300 SER B 312 1 13 HELIX 41 AE5 VAL B 316 LYS B 323 1 8 HELIX 42 AE6 GLY B 327 ILE B 354 1 28 HELIX 43 AE7 ILE B 356 GLN B 360 5 5 HELIX 44 AE8 THR B 382 LYS B 397 1 16 SHEET 1 AA1 3 VAL A 102 LEU A 103 0 SHEET 2 AA1 3 LEU A 247 TYR A 249 1 O VAL A 248 N LEU A 103 SHEET 3 AA1 3 TRP A 253 LYS A 257 -1 O TRP A 253 N TYR A 249 SHEET 1 AA2 2 LYS A 135 LYS A 136 0 SHEET 2 AA2 2 MET A 148 ASP A 149 -1 O ASP A 149 N LYS A 135 SHEET 1 AA3 2 VAL B 102 LEU B 103 0 SHEET 2 AA3 2 VAL B 248 TYR B 249 1 O VAL B 248 N LEU B 103 SHEET 1 AA4 2 TRP B 134 LYS B 136 0 SHEET 2 AA4 2 MET B 148 VAL B 150 -1 O ASP B 149 N LYS B 135 SSBOND 1 CYS A 308 CYS B 308 1555 1555 2.02 LINK NE2 HIS A 346 FE HEM A 502 1555 1555 1.76 LINK N08 HS0 A 501 FE HEM A 502 1555 1555 2.12 LINK NE2 HIS B 346 FE HEM B 502 1555 1555 1.85 LINK N08 HS0 B 501 FE HEM B 502 1555 1555 2.15 CRYST1 85.594 96.793 130.983 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011683 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007635 0.00000